With the share price taking a breather at the moment I have been trying to gain an understanding of who is selling.
It appears the bottom end of the register is in sell mode and the expiration date of Options and the Strike Price may also be having an effect, although the top 40 shareholders are primarily staying put.
Perhaps the patience of some is wearing thin, but trials, registration, development and the FDA take time to facilitate a product going to market, although my understanding is the Early Feasibility Study results were about 30% superior to the opposition and AVR's fundamentals are still acceptable.
And what I do like is that WP has not made any claims that have not been supported by fact, so in the end to support a financial return for shareholders there needs to be product approval, or a takeover. Again time consuming.
AVR Price at posting:
$16.15 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)